Clinical Trial

Standard-of-care Systemic Therapy With or Without Local Therapy in Patients With Oligoprogressive Non-Small Cell Lung Cancer(NSCLC）

Name: Standard-of-care Systemic Therapy With or Without Local Therapy in Patients With Oligoprogressive Non-Small Cell Lung Cancer(NSCLC） — clinical trial record (NCT07076693)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting Phase 2/3

View on ClinicalTrials.gov →

Summary

This is a randomized, controlled, phase II/III clinical study to evaluate the efficacy and safety of stand-of-care systemic therapy with local therapy versus stand-of-care systemic therapy in patients with oligoprogressive non-small cell lung cancer(NSCLC).

Trial Details

NCT Number	NCT07076693
Lead Sponsor	Shanghai Chest Hospital
Conditions	OligoProgressive Metastatic Disease, Non-Small Cell Lung Cancer
Enrollment	97 participants
Start Date	2025-06-03
Primary Completion	2028-05-31 (estimated)
Study Completion	2028-05-31 (estimated)
Updated on ClinicalTrials.gov	2025-07-22